Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Troisi, R.
Right arrow Articles by Hoover, R. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Troisi, R.
Right arrow Articles by Hoover, R. N
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology 2003;32:455-460
© International Epidemiological Association 2003


Perinatal Epidemiology

Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies

Rebecca Troisi1, Nancy Potischman2, James M Roberts3,4, Roberta Ness3,5, William Crombleholme3,4, David Lykins3,4, Pentti Siiteri6 and Robert N Hoover1

1 Division of Cancer Epidemiology and Genetics,
2 Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
3 Magee-Womens Research Institute,
4 Department of Obstetrics Gynecology and Reproductive Sciences,
5 Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
6 University of California San Francisco School of Medicine, San Francisco, CA, USA.

Correspondence:
Dr Rebecca Troisi, Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd., Bethesda, MD 20892–7246, USA. E-mail:
troisir{at}mail.nih.gov

Background Epidemiological studies show a substantially reduced risk of breast cancer in adult daughters of preeclamptic pregnancies, and modest risk reductions have been demonstrated for mothers also. Alterations in pregnancy hormone concentrations, particularly lower in utero exposure to oestrogen, are hypothesized to mediate this association.

Methods Pregnancy hormone concentrations were measured in maternal sera collected at hospital admission for labour and delivery from 86 preeclamptic and 86 uncomplicated, singleton pregnancies matched on length of gestation, maternal age, parity, and type of delivery.

Results Case and control pregnancies were similar in several maternal and pregnancy factors. Serum unconjugated oestradiol, oestrone, and oestriol concentrations were not lower in preeclamptic pregnancies in a matched analysis with adjustment for race and whether blood was collected before or after labour commenced. Serum unconjugated androstenedione (506.3 versus 316.0 ng/dl; P = 0.0007) and testosterone concentrations (214.5 versus 141.9 ng/dl; P = 0.004), however, were significantly higher in preeclamptic compared with control pregnancies, whereas dehydroepiandrosterone (DHEA) and DHEA sulphate did not differ.

Conclusions These data do not support the hypothesis that cancer risk in mothers and offspring of preeclamptic pregnancies is explained by exposure to lower maternal blood oestrogen concentrations, but raise the possibility that androgens play a role.


Keywords Hormones, preeclampsia, cancer, oestrogens, androgens, in utero

Accepted 6 January 2003


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Pettersson, L. Richiardi, S. Cnattingius, M. Kaijser, and O. Akre
Gestational Hypertension, Preeclampsia, and Risk of Testicular Cancer
Cancer Res., November 1, 2008; 68(21): 8832 - 8836.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Troisi, P. Lagiou, D. Trichopoulos, B. Xu, L. Chie, F. Z. Stanczyk, N. Potischman, H.-O. Adami, R. N. Hoover, and C.-C. Hsieh
Cord Serum Estrogens, Androgens, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 in Chinese and U.S. Caucasian Neonates
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 224 - 231.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Troisi, N. Potischman, and R. N. Hoover
Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. M. Faupel-Badger, C.-C. Hsieh, R. Troisi, P. Lagiou, and N. Potischman
Plasma Volume Expansion in Pregnancy: Implications for Biomarkers in Population Studies
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1720 - 1723.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. B. Terry, M. Perrin, C. M. Salafia, F. F. Zhang, A. I. Neugut, S. L. Teitelbaum, J. Britton, and M. D. Gammon
Preeclampsia, Pregnancy-related Hypertension, and Breast Cancer Risk
Am. J. Epidemiol., May 1, 2007; 165(9): 1007 - 1014.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. G. Spector, S. M. Davies, L. L. Robison, J. M. Hilden, M. Roesler, and J. A. Ross
Birth Characteristics, Maternal Reproductive History, and the Risk of Infant Leukemia: A Report from the Children's Oncology Group
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 128 - 134.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Troisi, L. Vatten, R. N. Hoover, J. M. Roberts, B. F. Cole, and N. Potischman
Maternal androgen and estrogen concentrations are not associated with blood pressure changes in uncomplicated pregnancies.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 2013 - 2015.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. R. Palmer, L. A. Wise, E. E. Hatch, R. Troisi, L. Titus-Ernstoff, W. Strohsnitter, R. Kaufman, A. L. Herbst, K. L. Noller, M. Hyer, et al.
Prenatal diethylstilbestrol exposure and risk of breast cancer.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1509 - 1514.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Paradisi, A. Biaggi, R. Savone, F. Ianniello, C. Tomei, L. Caforio, and A. Caruso
Cardiovascular Risk Factors in Healthy Women with Previous Gestational Hypertension
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1233 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Ross
High Birthweight and Cancer: Evidence and Implications
Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 1 - 2.
[Full Text] [PDF]


Home page
JAMAHome page
S. Cnattingius, A. Torrang, A. Ekbom, F. Granath, G. Petersson, and M. Lambe
Pregnancy Characteristics and Maternal Risk of Breast Cancer
JAMA, November 16, 2005; 294(19): 2474 - 2480.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
E. Kajantie, R. Kaaja, O. Ylikorkala, S. Andersson, and H. Laivouri
Adiponectin Concentrations in Maternal Serum: Elevated in Preeclampsis But Unrelated to Insulin Sensitivity
Reproductive Sciences, September 1, 2005; 12(6): 433 - 439.
[Abstract] [PDF]


Home page
BMJHome page
A. Taylor
Pre-eclampsia and the risk of cancer
BMJ, April 17, 2004; 328(7445): 909 - 910.
[Full Text] [PDF]


Home page
BMJHome page
O. Paltiel, Y. Friedlander, E. Tiram, M. Barchana, X. Xue, and S. Harlap
Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort
BMJ, April 17, 2004; 328(7445): 919.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Troisi, N. Potischman, C. N. Johnson, J. M. Roberts, D. Lykins, G. Harger, N. Markovic, P. Siiteri, and R. N. Hoover
Estrogen and Androgen Concentrations Are Not Lower in the Umbilical Cord Serum of Pre-eclamptic Pregnancies
Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1268 - 1270.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.